Center president and director joins ranks of nation's most esteemed thinkers and doers with election to American Academy of Art and Sciences' 2012 class of fellows
April 17, 2012
| By Dean Forbes
Fred Hutchinson Cancer Research Center President and Director Dr. Larry Corey has been elected to membership in the American Academy of Arts and Sciences, one of the nation's oldest and most prestigious honorary societies and independent policy-research centers.
Clinical Research Division's Philip Greenberg honored for pioneering work to bring adoptive T-cell therapy from bench to bedside
Sept. 26, 2011
Dr. Philip Greenberg, head of the Fred Hutchinson Cancer Research Center’s Immunology Program in the Clinical Research Division, is the joint recipient of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology for his pioneering research in adoptive T-cell therapy.
Amanda Claire McIntyre will use the national award from the Joanna M. Nicolay Melanoma Foundation to complete her doctorate in the UW’s Molecular & Cellular Biology program
April 18, 2011
| By Dean Forbes
Amanda Claire McIntyre, a University of Washington graduate student in the Fred Hutchinson Cancer Research Center's Yee Lab, was one of seven graduate students nationally chosen to receive a competitive $10,000 research scholar award by the Joanna M. Nicolay Melanoma Foundation.
Vaccine and Infectious Disease Division co-director will fill vacancy left by Larry Corey, incoming president and director
Nov. 1, 2010
Dr. Julie McElrath, co-director of the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Division, is a new senior vice president at the Hutchinson Center. She replaces Dr. Larry Corey, who assumes the role of Center president and director in January.
Center to lead national, multi-institutional clinical trials effort
Oct. 11, 2010
In an effort to accelerate clinical trials of promising cancer immunotherapies, the National Cancer Institute has awarded a five-year, $17 million grant to the Fred Hutchinson Cancer Research Center Clinical Research Division’s Dr. Mac Cheever to establish a new Cancer Immunotherapy Trials Network.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.